1. Urotensin receptors as a new target for CLP induced septic lung injury in mice
   Elif Cadirci et al, 2019, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. UROTENSİN II’NİN İNSAN OSTEOBLAST HÜCRELERİNDE ENFLAMASYONLA İLİŞKİLİ ROLÜ
   Hamza Malik OKUYAN et al, 2021, İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi CrossRef
3. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway
   Panpan Wei et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
4. Urotensin II levels in patients with inflammatory bowel disease
   Damir Alicic et al, 2021, World Journal of Gastroenterology CrossRef
5. Urotensin II: an inflammatory cytokine
   Shui-lin Sun et al, 2019, Journal of Endocrinology CrossRef
6. Activation of the Nuclear Receptor Fxr Improves Intestinal Cell Tolerance to Ischemia–Reperfusion Injury
   Xuan Wang et al, 2018, Shock CrossRef
7. Urotensin-II Prevents Cartilage Degeneration in a Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis
   Menderes Yusuf Terzi et al, 2022, International Journal of Peptide Research and Therapeutics CrossRef
8. Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats
   Tu Wang et al, 2020, Life Sciences CrossRef
9. Urotensin II level is elevated in inflammatory bowel disease patients
   Yan Zhang et al, 2022, World Journal of Gastroenterology CrossRef